Quest Diagnostics Incorporated (DGX) : During the past 4 weeks, traders have been relatively bearish on Quest Diagnostics Incorporated (DGX), hence the stock is down -0.49% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.99% relative to the S&P 500. The 4-week change in the price of the stock is -0.11% and the stock has fallen -1.03% in the past 1 week.
Quest Diagnostics Inc. is up 11.51% in the last 3-month period. Year-to-Date the stock performance stands at 21.29%. The stock has recorded a 20-day Moving Average of 0.54% and the 50-Day Moving Average is 3.31%.
Quest Diagnostics Incorporated (NYSE:DGX): The stock opened at $84.84 on Friday but the bulls could not build on the opening and the stock topped out at $84.97 for the day. The stock traded down to $84.17 during the day, due to lack of any buying support eventually closed down at $84.91 with a loss of -0.32% for the day. The stock had closed at $85.18 on the previous day. The total traded volume was 971,487 shares.
Also, In the latest statement by the brokerage house, Jyske Bank downgrades its outlook on Quest Diagnostics Incorporated (NYSE:DGX). The current rating of the shares is Sell, according to the research report released by the firm. The rating by the firm was issued on June 24, 2016.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.